|
|
Post by madog365 on May 4, 2017 10:05:21 GMT -5
One Drop takes blood glucose monitoring system direct to consumer through Amazon "With the rise of telemedicine, mobile health tracking, wearables and customized medical devices for immediate purchase online, consumers now have the power to receive the personalized, data-driven care they deserve without having to jump through insurance hurdles," stated Jeff Dachis, CEO One Drop. "For the 30 million Americans with diabetes, the ability to order One Drop | Chrome on Amazon Prime is yet another step in the right direction. We are expanding our reach to serve more people with better service, delivering affordable, accessible and effective diabetes care wherever you are." Developed for those living with diabetes and prediabetes, the One Drop | Chrome meter delivers clinically proven, accurate blood glucose readings in five seconds. The blood glucose data are then wirelessly transmitted via Bluetooth to the One Drop | Mobile app. Users can view their blood glucose data alongside their medication, food and exercise data, which can be immediately shared with in-app diabetes coaches, health care teams and the One Drop community of nearly 200,000 users located in over 200 countries all over the world. For users looking for affordable diabetes supplies and expert advice from certified diabetes educators, One Drop offers the option to upgrade to their subscription services, which includes unlimited blood glucose testing supplies and unlimited coaching for less than the cost of a co-pay. One Drop has fully embraced the direct-to-consumer model, offering all products and services without requiring health insurance, prescriptions or medical appointments. www.drugstorenews.com/article/one-drop-takes-blood-glucose-monitoring-system-direct-consumer-through-amazon |
|
|
|
Post by orlon on May 4, 2017 10:12:31 GMT -5
Don't get to excited....back down to .72c last I looked. This appears to me to be a bone thrown to the shareholders just before the ASM in hopes the pitchforks will be left at the door. How long has it been before we've heard anything from the company? And all of a sudden a tid-bit of news? Maybe I'm just cynical in my old age but I've see this rodeo before.
|
|
|
|
Post by tw12 on May 4, 2017 10:16:26 GMT -5
Jeff Dachis (CEO of OneDrop) is creating a potentially huge community of PWD's that can reinforce each other's journey and solutions, communicating seamlessly and confidentially. He seems a solid, smart, highly commited dude in this interview (http://onedrop.today/about/press/) and the technology seems to be faultless and sophisticated.
Nice going, Mike Castagna! This is exactly the right kind of partnership we need.
|
|
|
|
Post by mnholdem on May 4, 2017 10:21:15 GMT -5
MannKind already has the BluHale bluetooth device, although there may be more involved here than simply linking up with the OneDrop app. The corporate website currently states, "The interactive user interface feature is a training tool and also probes the effects of varied inhalation efforts." For this to be a seamless system with the OneDrop app, the BluHale (or a new device) will need to measure the exact amount of Afrezza (insulin human) that the patient inhales, so that the OneDrop iPhone app can measure the precise affect of each specific cartridge (dose). This would be preferable to having the patient type in the cartridge size.
|
|
|
|
Post by gamblerjag on May 4, 2017 10:26:51 GMT -5
Don't get to excited....back down to .72c last I looked. This appears to me to be a bone thrown to the shareholders just before the ASM in hopes the pitchforks will be left at the door. How long has it been before we've heard anything from the company? And all of a sudden a tid-bit of news? Maybe I'm just cynical in my old age but I've see this rodeo before. . Yes or Orlon you are being cynical it's not like mankind called one touch yesterday and said hey let's tie shareholders over for 10 days would you want to do a collaboration? I'm guessing these things take many many months from start to finish it coincides more in my opinion with the start of things that Matt said are complicated and things take time |
|
|
|
Post by tarheelblue004 on May 4, 2017 10:29:32 GMT -5
3. Design innovation around packaging and exploration of a reusable Afrezza Inhaler with integrated Bluetooth technology.
I think packaging is the key word. It seems to me like style is a key aspect of One Drop's appeal...a core competency of the firm. They will probably start with BlueHale and try to make it more stylish to fit the One Drop brand. Seems simpler than starting over to create with a new Bluetooth inhaler.
|
|
|
|
Post by uvula on May 4, 2017 10:32:05 GMT -5
Don't get to excited....back down to .72c last I looked. This appears to me to be a bone thrown to the shareholders just before the ASM in hopes the pitchforks will be left at the door. How long has it been before we've heard anything from the company? And all of a sudden a tid-bit of news? Maybe I'm just cynical in my old age but I've see this rodeo before. . Yes or Orlon you are being cynical it's not like mankind called one touch yesterday and said hey let's tie shareholders over for 10 days would you want to do a collaboration? I'm guessing these things take many many months from start to finish it coincides more in my opinion with the start of things that Matt said are complicated and things take time Yes these things take many months from start to finish. Do you know what the first step is? A "memorandum of understanding to enter into a collaborative agreement " which is all that we have. |
|
|
|
Post by kbrion77 on May 4, 2017 10:35:57 GMT -5
3. Design innovation around packaging and exploration of a reusable Afrezza Inhaler with integrated Bluetooth technology. I think packaging is the key word. It seems to me like style is a key aspect of One Drop's appeal...a core competency of the firm. They will probably start with BlueHale and try to make it more stylish to fit the One Drop brand. Seems simpler than starting over to create with a new Bluetooth inhaler. This is years and years and years away. |
|
|
|
Post by factspls88 on May 4, 2017 11:32:01 GMT -5
Jeff Dachis, the One Drop founder, was also the founder of Razorfish, a cutting edge digital marketing ad agency. My daughter worked for them in Manhattan. With his expertise One Drop should get great exposure with early adopters in the diabetes category. With Afrezza as part of the mix, we should get greater awareness. Perhaps this could be an opportunity to get greater coverage of Afrezza's advantages. For you downers out there, have some vision. I see this as a huge plus. Maybe even game changing. You've gotta have vision if you want to win big. Full disclosure I have been averaging down and bought more today. Good luck all.
|
|
|
|
Post by buyitonsale on May 4, 2017 12:23:33 GMT -5
"Access, Cost Savings and Convenience initiatives, intended to simplify the complexity of starting and staying on mealtime insulin"
Should be interesting to see how these initiatives are reflected in the collaboration agreement.
"We think there's an opportunity to be the Uber of diabetes."
|
|
|
|
Post by babaoriley on May 4, 2017 12:32:37 GMT -5
Jeff Dachis, the One Drop founder, was also the founder of Razorfish, a cutting edge digital marketing ad agency. My daughter worked for them in Manhattan. With his expertise One Drop should get great exposure with early adopters in the diabetes category. With Afrezza as part of the mix, we should get greater awareness. Perhaps this could be an opportunity to get greater coverage of Afrezza's advantages. For you downers out there, have some vision. I see this as a huge plus. Maybe even game changing. You've gotta have vision if you want to win big. Full disclosure I have been averaging down and bought more today. Good luck all. Facts, you're always a winner with me with that avatar! And, you're in the perfect stock if you like to average down, the opportunities apparently are boundless! Agree with your vision comment, however, I'm gonna need some expensive night-vision googles for this one. (anybody ever use those things, I mean good ones? Incredible!) |
|
|
|
Post by dreamboatcruise on May 4, 2017 13:46:49 GMT -5
MannKind already has the BluHale bluetooth device, although there may be more involved here than simply linking up with the OneDrop app. The corporate website currently states, "The interactive user interface feature is a training tool and also probes the effects of varied inhalation efforts." For this to be a seamless system with the OneDrop app, the BluHale (or a new device) will need to measure the exact amount of Afrezza (insulin human) that the patient inhales, so that the OneDrop iPhone app can measure the precise affect of each specific cartridge (dose). This would be preferable to having the patient type in the cartridge size.
The bluhale I believe is simply measuring the volume of air, not the powder content. They'd likely need to somehow key the cartridges (electronic or mechanical) so that the inhaler could tell how many units. They would need to develop a far cheaper version if they wanted it to be disposable after 14 days. Probably it would make sense to simply detect the cartridge size and forget about measuring breath volume, since the whole premise of the inhaler is that if done correctly, the the dosing is close enough to not have to worry about decimal points of units. I wonder if they'd need to do clinical trials again with new inhaler or if it could be proven by design to deliver the powder exactly the same. I wonder why they don't consider simply using the existing BluHale which attaches to a dreamboat. Obviously no FDA issue in that case. Though still problem of not knowing which cartridge is being used. Also makes it bulkier. If bulkier, some/many users might simply prefer making the notation of Afrezza dose in the app manually. I think I'd prefer that vs having a bulkier/heavier inhalation device. |
|
|
|
Post by dreamboatcruise on May 4, 2017 13:57:13 GMT -5
Don't get to excited....back down to .72c last I looked. This appears to me to be a bone thrown to the shareholders just before the ASM in hopes the pitchforks will be left at the door. How long has it been before we've heard anything from the company? And all of a sudden a tid-bit of news? Maybe I'm just cynical in my old age but I've see this rodeo before. . Yes or Orlon you are being cynical it's not like mankind called one touch yesterday and said hey let's tie shareholders over for 10 days would you want to do a collaboration? I'm guessing these things take many many months from start to finish it coincides more in my opinion with the start of things that Matt said are complicated and things take time The fastest MOU I've done occurred like this. We knew middle management from the other company from general professional circles and trade shows. They called and asked for meeting. Set up 10-12 days later without an agenda yet, just general collaboration. Day before meeting they sent email explaining their intent and forwarded draft MOU for what they intended. Meeting was discussion of that. Two days to tweak terms and wording to get signed MOU. All told a approximately two weeks. Others can take longer... partly depending on how detailed the intent is, how binding the terms are and whether either party might be asked to give up other active opportunities. If the terms are very broad and neither OneDrop nor MNKD had other opportunities that this announcement might derail (likely not) then an MOU could be pretty quick. |
|
|
|
Post by matt on May 4, 2017 14:21:30 GMT -5
You are correct that an MOU can go very quickly or they can drag out. In my experience either the other side wants to do the deal as much as you, in which case nobody quibbles too much about a letter that will soon be replaced by a definitive contract, or they over-lawyer the terms. The longer the negotiations drag out, the less chance for a mutually beneficial deal. I have managed one in under an hour, we were really eager to sell the asset and they were really eager to buy, but those don't happen very often.
|
|
|
|
Post by orlon on May 4, 2017 15:00:26 GMT -5
But here's the bottom line: No AFREZZA sales=No revenue=No increase in PPS=No company...poof! If they can't sell AFREZZA they can't stay in business, it makes little difference who they collaborate with. A MOU, and I think most of have had experience in these, is not an action plan that leads to an increase in sales.
|
|
